tykhr
sign in
free sign up
Charles River Laboratories
Diagnostics & Research
Healthcare
CRL
49.32 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
154.22
52 week high
220.69
high
154.94
52 week low
0.00
low
149.91
growth
-26.99 %
previous Close
153.89
P/E ratio
market cap
8.23 B
div yield
0
usd
Jun 2025
qoq
revenue
1.03 B
4.87 %
net incoming
52.33 M
105.45 %
eps
0.00 %
0.00 %
eps surprise
-100.00 %
net profit margin
5.07 %
2.00 %
operating incoming
100.13 M
34.10 %
net change in cash
-46.99 M
-279.63 %
cash on hand
183 M
-20.29 %
cost of revenue
0.00 %
top